Andre C. Matta

Niteroi, RJ, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

First-In-Human Safety, Pharmacokinetics, and Pharmacodynamics of VENT-02 Freebase, a CNS-Penetrant NLRP3 Inhibitor.

First-In-Human Safety, Pharmacokinetics, and Pharmacodynamics of VENT-02 Freebase, a CNS-Penetrant NLRP3 Inhibitor.

Journal: Clinical and translational science

Published: February 19, 2026

Brain fog in Parkinson's disease: unraveling mechanisms and measuring impact.

Brain fog in Parkinson's disease: unraveling mechanisms and measuring impact.

Journal: Frontiers in neurology

Published: February 04, 2025

Impacts of environmental tobacco smoke on the onset and progression of multiple sclerosis: a systematic review.

Impacts of environmental tobacco smoke on the onset and progression of multiple sclerosis: a systematic review.

Journal: Arquivos de neuro-psiquiatria

Published: March 15, 2024

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial.

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial.

Journal: The Lancet. Neurology

Published: January 28, 2021

Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study.

Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: September 28, 2018

Efficacy of dimethyl fumarate in Japanese multiple sclerosis patients: interim analysis of randomized, double-blind APEX study and its open-label extension.

Efficacy of dimethyl fumarate in Japanese multiple sclerosis patients: interim analysis of randomized, double-blind APEX study and its open-label extension.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: September 11, 2018

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice.

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice.

Journal: Neurology

Published: August 02, 2018

72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension.

72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension.

Journal: Advances in therapy

Published: June 21, 2018

Relationship between Expanded Disability Status Scale scores and the presence of temporomandibular disorders in patients with multiple sclerosis.

Relationship between Expanded Disability Status Scale scores and the presence of temporomandibular disorders in patients with multiple sclerosis.

Journal: European journal of dentistry

Published: April 17, 2018

Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis.

Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis.

Journal: Arquivos de neuro-psiquiatria

Published: March 17, 2018

Normative values of the Brief Repeatable Battery of Neuropsychological Tests in a Brazilian population sample: discrete and regression-based norms.

Normative values of the Brief Repeatable Battery of Neuropsychological Tests in a Brazilian population sample: discrete and regression-based norms.

Journal: Arquivos de neuro-psiquiatria

Published: September 16, 2017

No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South.

No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South.

Journal: Arquivos de neuro-psiquiatria

Published: August 07, 2016

Showing 1-12 of 32

Last Updated: 09/26/2026